Patent 8716323 was granted and assigned to Bristol-Myers Squibb on May, 2014 by the United States Patent and Trademark Office.
Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.